Company profile
Green Thumb Industries Inc.
OTC: GTBIF · Healthcare · Drug Manufacturers - Specialty & Generic
#145 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
72BFH 83DQ 57GM 68SS 72
v0.1 · 65/100 weight · provisional
↑ workforce scale, revenue growth (YoY) · ↓ growth stability, listing tenure
Methodology →Revenue TTM
$1.2B
Rev growth YoY (TTM)
+4.8%
Net income (FY)
$114.2M
Employees
5,000
as of 2026-08-09
Market cap
$1.5B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2B$1.2B2025
Net income$114.2M$114.2M2025
Operating income$137.7M$137.7M2025
Total assets$2.8B$2.8B2025
Liabilities$879.4M$879.4M2025
Equity$1.9B$1.9B2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Retail71%
Consumer Packaged Goods58%
Intersegment Eliminations and Corporate-28%
By geography
Not disclosed.
The read
What is Green Thumb Industries Inc.’s revenue?
Green Thumb Industries Inc. booked $1.2B in FY2025 revenue, growing 303% year over year — faster than 92% of Healthcare companies we track, at a 9.7% net margin.
Peers · Healthcare
Omnicell, Inc.78B+Trulieve Cannabis Corp.63CTrulieve Cannabis Corp.——Sotera Health Company70BNovavax, Inc.69BBabylon Holdings Limited——Neighbors
Cook →Key facts
CEOBenjamin Kovler
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersChicago, IL
ExchangeOTC: GTBIF
Employees5,000
IPO date2018-06-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.